Vericel Reports 4Q18 MACI Revenue of $25.1MM, +56% vs. 4Q17

By Mike Evers

Vericel reports 4Q18 MACI revenue of USD $25.1MM, +56% vs. 4Q17, with 2018 full year revenue of $67.7MM, +54.2% vs. 2017.

Member-Only Content

SUBSCRIBE Login

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Revenue Report